iPad game effective in treating lazy eye

Patching the unaffected eye has been the standard treatment for amblyopia (lazy eye) but a special iPad game has been found to be more effective than patching. A study was recently published in the online JAMA Ophthalmology.  Researchers at the Retina Foundation in Dallas randomly assigned 28 children diagnosed with amblyopia to treatment using a […]

New treatment for uveitis

A recent study published in the New England Journal of Medicine details the findings that the arthritis medication, adalimumab, can effectively treat uveitis. Researchers were looking to determine what effect adalimumab has on patients with uveitis. Adalimumab is a steroid-free, injection that has few side effects and is used to treat rheumatic diseases. 217 adults […]

Improved therapy for retinoblastoma patients

The addition of topotecan to a multi-drug chemotherapy helped to maintain high cure rates for the devastating eye cancer and helped preserve vision and reduced the likelihood of developing treatment-related leukemia. Results of the 10-year follow-up study were recently published online in the Journal of Clinical Oncology. Retinoblastoma is an eye cancer that occurs in […]

Warning for stroke patients with wet AMD

Patients suffering from wet macular degeneration who have had a stroke are being warned against using bevacizumab (Avastin®) within a 6 month period after the stroke. This is because people who had a bevacizumab eye injection within 3 to 6 months after a stroke had a significantly higher mortality rate than patients who did not receive injections. […]

Lucentis Prefilled Syringe approved by FDA

Doctors will now have an alternative when it comes to administering Lucentis injections for patients with advanced macular degeneration or diabetic retinopathy. The FDA recently announced its approval of .5 mg pre-filled syringes of Luncentis for the treatment of patients with wet age-related macular degeneration, macular edema and retinal vein occlusion. Currently, physicians have several […]

Testing blood sugar with a contact lens

For diabetics who must endure blood testing to check their glucose levels, a pain-free method may soon be available in the form of a contact lens. Researchers at the University of Houston published results of a study in the journal Advanced Materials. Armed with the knowledge that glucose is present in blood as well as […]

Be wary if considering stem cell therapy

With stem cell therapy for eye disease being the current trendy news topic, many people are eager to jump the gun and rush into trying it. These therapies are currently being researched and have not been approved by the Food and Drug Administration to be safe and effective. Since there are no stem cell therapies […]

Visual acuity not maintained with anti-VEGF

A follow-up study was conducted to determine the long-term benefit and visual acuity outcomes of patients undergoing anti-VEGF treatments, such as Eyelea, Lucentis and Avastin. What researchers found was that visual gains were not maintained after 5 years of injections. Records of 647 patients with wet AMD were analyzed in the Comparison of Age-Related Macular […]

Cardio drug helpful in treating surfer’s eye

Researchers from Ariel University in Israel recently examined the affect the commonly prescribed cardiovascular drug, dipryidamole, had on treating pterygium, otherwise known as surfer’s eye. Surfer’s eye is caused by a benign growth of the conjunctiva over the white of the eye. The condition is commonly found in surfers (hence, the name) but is more prevalent in […]

Eylea effective for Diabetic Retinopathy

A two-year clinical trial has found that diabetic patients suffering from severe vision loss from diabetic macular edema benefit the most from receiving treatment with Eylea versus Avastin or Lucentis. Eylea was just approved for use by the FDA for treating diabetic macular edema patients last year. The study was conducted by the National Institutes […]